Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Four revelations from Minnesota’s first 340B transparency report
Four oral GLP-1R products in Phase III trials as race intensifies
Gilead looks beyond Trodelvy with Tubulis alliance
*please scroll down for all the latest news*
